Fintech M&A is booming, but so is regulatory scrutiny. Competition authorities are increasingly bullish to claim jurisdiction over fintech deals and to pursue novel theories of harm. At the same time, the scope of foreign investment regulation has widened due to the pandemic and ongoing trade tensions, adding yet another piece to the regulatory jigsaw puzzle faced by deal-doers. Getting your fintech deal cleared is no longer a given, and even if you get your merger control and foreign investment clearance, there is still a host of other financial regulation that applies before, throughout and after the deal process.
In our 15th episode, podcast host Jenn Mellott speaks with Rod Carlton, Christine Laciak and Cyrus Pocha to discuss these developments.
Essential Antitrust #34: Olivier Guersent on competition enforcement: current trends
Essential Antitrust #33: Antitrust insights in Asia: navigating complex regulations and investment challenges
MedTech Across Borders – Recent Developments in Japan and the US
MedTech x Creating System Change – Reducing clinician burnout, effectively using AI and more
Essential Antitrust #32: New US HSR Rules and Merger Guidelines: key takeaways
Managing risk in Asia #7: Managing licensing and collaboration risks in the life sciences arena in Asia
Essential Antitrust #31: Recent developments in antitrust, data and IP – generative AI and MedTech
Essential Antitrust #30: ASSA ABLOY/Spectrum Brands: a breakthrough for M&A remedies in the US?
Essential Antitrust #29: Microsoft/Activision: parallel reviews in high-innovation digital deals
Global Perspectives on Health Data Offerings and Considerations for Innovators
Essential Antitrust #28: Collusion or collaboration: competition and the fight for net zero
Essential Antitrust #27: Some Key Takeaways from the Enforcers Roundtable at the 2023 ABA Antitrust Spring Meeting
MedTech Diversity and Inclusion – A Conversation with Jhaymee Tynan
Episode #1: The EU’s Corporate Sustainability Due Diligence Directive– a turning point for business
Essential Antitrust Asia #8: Hot topics in China antitrust
Tax Matters: Ready, Steady, Growth – Business tax implications of the UK Spring Budget 2023
Essential Antitrust #26: Foreign subsidy control: EU gears up to review deals and business conduct
Essential Antitrust #25: Antitrust in 2023: 10 key themes - growing unpredictability and brand new enforcement tools
MedTech - A Conversation with Stacy Hostetler
Essential Antitrust #24: Cartel enforcement is back: dawn raids in Europe and new targets in the US
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
Aligned Money Show
Gorse Culture PODcast : The H.R. Detective Agency!
HCI Leadership Revolution
The Ramsey Show
Planet Money